A software system to improve Applied Behavior Analysis for autism treatment
Acuity - A Clinical Decision Support System for Applied Behavior Analysis
This study is testing a new software called Acuity that helps Behavior Analysts and Technicians provide better support for kids with autism by making it easier to plan treatments and track progress, so everyone can work together more effectively for better results.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Experiad, LLC NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project ID | NIH-10914301 on NIH RePORTER |
What this research studies
This research focuses on developing a clinical decision support software called Acuity, designed to assist Behavior Analysts and Technicians in delivering Applied Behavior Analysis (ABA) for autism treatment. The software will integrate with existing systems used in autism therapy clinics, enhancing treatment planning, progress tracking, and data management. By employing machine learning and statistical algorithms, Acuity aims to provide real-time insights and improve the efficiency of clinical decisions, ultimately leading to better outcomes for patients. The research will involve a functional impact study with Behavior Analysts from multiple clinics to evaluate the software's effectiveness in practice.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autism who are receiving Applied Behavior Analysis therapy.
Not a fit: Patients who are not receiving ABA therapy or those with conditions unrelated to autism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment plans for individuals with autism, improving their overall outcomes.
How similar studies have performed: Previous research has shown that clinical decision support systems can significantly enhance treatment delivery in various medical fields, suggesting a promising outlook for this novel approach in autism therapy.
Where this research is happening
Honolulu, United States
- Experiad, LLC — Honolulu, United States (Active)
Researchers
- Principal investigator: Jakobovits, Rex M — Experiad, LLC
- Study coordinator: Jakobovits, Rex M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.